Table 3 Histopathologic findings of IgG positive and IgG negative patients
IgG positive patients (n: 179) | IgG negative patients (n: 764) | p | |
|---|---|---|---|
Total glomerulus number | 18 ± 10 | 17 ± 10 | NS |
Global sclerotic glomerulus number | 4 ± 4 | 4 ± 4 | NS |
Segmental sclerotic glomerulus number | 2 ± 3 | 1 ± 2 | NS |
Cellular crescent number | 0 ± 1 | 0 ± 1 | NS |
Fibrocellular crescent number | 0 ± 1 | 0 ± 2 | NS |
Basal membrane thickening | 22.9% | 20.9% | NS |
Mesangial proliferation | 86.2% | 86.4% | NS |
Endocapillary proliferation | 24.2% | 18.3% | NS |
Interstitial inflammation | 72.0% | 74.7% | NS |
Tubular atrophy/interstitial fibrosis | |||
T0 | 58.5% | 41.3% | < 0.05 |
T1 | 35.3% | 44.7% | < 0.05 |
T2 | 6.2% | 11% | NS |
IgA staining | |||
(+) | 5.6% | 5.9% | NS |
(++) | 27.5% | 33.5% | NS |
(+++) | 68.6% | 60.5% | NS |
Mesangial hypercellularity | |||
M0 | 23.5% | 22.2% | NS |
M1 | 76.5% | 78.8% | NS |
Endocapillary hypercellularity | |||
E0 | 66.4% | 78.7% | NS |
E1 | 33.6% | 21.3% | NS |
Segmental glomerulosclerosis | |||
S0 | 44.9% | 39.5% | NS |
S1 | 55.1% | 60.5% | NS |